Literature DB >> 30711921

Six-year incidence and progression of diabetic retinopathy in Indian adults: the Singapore Indian Eye study.

Neelam Kumari1,2,3,4, Mayuri Bhargava2,3,5, Duc Quang Nguyen2, Alfred Tau Liang Gan2, Gavin Tan2,3,5, Ning Cheung2,3, Nicholas Tan5, Charlene Wong5, Jie Jin Wang3, Paul Mitchell6, Ecosse L Lamoureux2,3, Ching Yu Cheng2,3,5, Tien Yin Wong2,3,5, Charumathi Sabanayagam7,3,5.   

Abstract

AIMS: Diabetes is a major public health problem in migrants and ethnic minorities worldwide. We determined the incidence and risk factors of diabetic retinopathy (DR) in migrant Indians living in Singapore.
METHODS: We included data from 759 Indian adults with diabetes, who participated in the baseline (aged 40-80 years, 2007-2009) and 6-year follow-up 2012-2015 of the Singapore Indian Eye Study. Retinal photographs were graded for the presence and severity of DR using modified Airlie House Classification. Incidence was assessed in participants who were free of DR at baseline visit (n=501), while progression in those with DR but free of proliferative DR at baseline visit (n=189). Risk factors included demographic, lifestyle, socioeconomic, family history, genes, duration of diabetes, glycaemic control, insulin use, ocular and clinical factors.
RESULTS: The 6-year age-standardised DR incidence and progression were 21.89% and 33.45%, respectively. HbA1c (risk ratio (RR) 1.41, 95% CI 1.28 to 1.55 per unit increase), current smoking (RR 1.63, 95% CI 1.02 to 2.62) and insulin use (RR 2.63, 95% CI 1.44 to 4.82) were associated with higher incidence, whereas estimated cerebrospinal fluid pressure (RR 0.90, 95% CI 0.82 to 0.98) and body mass index (BMI) (RR 0.74, 95% CI 0.60 to 0.93) were associated with lower incidence of DR. Higher HbA1c (RR 1.26, 95% CI 1.13 to 1.42), BMI (RR 1.26, 95% CI 1.02 to 1.56) and estimated cerebrospinal fluid pressure (RR 1.11, 95% CI 1.02 to 1.21) were associated with DR progression. The population attributable risk of HbA1c >8% was 41.29% and 49.63% for DR incidence and progression.
CONCLUSION: DR incidence and progression in migrant Indians living in Singapore was more than double that reported in Indians living in urban India. Consistent with past studies, poor glycaemic control was an important predictor for incidence and progression of DR. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; public health; retina

Mesh:

Substances:

Year:  2019        PMID: 30711921     DOI: 10.1136/bjophthalmol-2018-313282

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic Patients.

Authors:  Jiaxian Chen; Yanan Wan; Jian Su; Zheng Zhu; Engchun Pan; Chong Shen; Jinbo Wen; Kai Wang; Hao Yu; Yu Qin; Lan Cui; Jinyi Zhou; Ming Wu
Journal:  Acta Diabetol       Date:  2021-10-28       Impact factor: 4.280

2.  Differential Effect of Generalized and Abdominal Obesity on the Development and Progression of Diabetic Retinopathy in Chinese Adults With Type 2 Diabetes.

Authors:  Xiaoyan Han; Huimin Wu; Youjia Li; Meng Yuan; Xia Gong; Xiao Guo; Rongqiang Tan; Ming Xie; Xiaoling Liang; Wenyong Huang; Hua Liu; Lanhua Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-27

3.  The War on Diabetic Retinopathy: Where Are We Now?

Authors:  Tien Y Wong; Charumathi Sabanayagam
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec

Review 4.  Research Progress of Artificial Intelligence Image Analysis in Systemic Disease-Related Ophthalmopathy.

Authors:  Yuke Ji; Nan Chen; Sha Liu; Zhipeng Yan; Hui Qian; Shaojun Zhu; Jie Zhang; Minli Wang; Qin Jiang; Weihua Yang
Journal:  Dis Markers       Date:  2022-06-24       Impact factor: 3.464

5.  Analysis of factors related to diabetic retinopathy in patients with newly diagnosed type 2 diabetes: a cross-sectional study.

Authors:  Zhaohu Hao; Xiao Huang; Yongzhang Qin; Huanming Li; Fengshi Tian; Rong Xu; Baocheng Chang; Hailin Shao
Journal:  BMJ Open       Date:  2020-02-10       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.